http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2549673-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d1c952f9b23a8d349d74064aa544f21
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N2-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00
filingDate 2014-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82e0272587baa7957f2b75bd879c3f8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4c28fadb1d27e334c957c1fb6d6a930
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80b92fe9ea74558a336924f28dd97205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eaf8b5c6200652077b889389d9ceb96d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ae422d60085cffdac0f3f6c7305f6e4
publicationDate 2015-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2549673-C1
titleOfInvention Method of treating early manifestations of age-related macular retinal degeneration
abstract FIELD: medicine. n SUBSTANCE: transcranial influence by a travelling pulse magnetic field with the induction of 35 mT, inversion frequency from 1 to 16 Hz, reversion time of 1 minute, is carried out. Then the eye is exposed to laser radiation with a wavelength of 0.633 mcm, in a mode of continuous radiation with the outlet power of 2.4 mW. On the first day the exposure to the magnetic field lasts 5 minutes, to the laser radiation - 1 minute. On the second day the exposure lasts 6 and 2 minutes, respectively. On the third day it lasts 7 and 3 minutes, respectively. From 4 to 10 day the exposure lasts 8 and 4 minutes, respectively. The influence is realised on each eye alternately. n EFFECT: method improves the microcirculation of the retina, reduces paravasal retina oedema, ensures the increase of the vision acuity and reduces the number of photopsias. n 11 dwg, 3 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2750969-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2776695-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2803580-C1
priorityDate 2014-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2408335-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A0R4IPQ8
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533737
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID553297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411029818
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54678486
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280816
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP06909
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3075
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID155012
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445580
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12628

Total number of triples: 33.